Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Eastman Chemical Co Stock Research

EMN

77.78USD-0.64(-0.82%)Delayedas of 21 Sep 2023, 10:11 am
Watchlist

Market Summary

USD77.78-0.64
Delayedas of 21 Sep 2023, 10:11 am
-0.82%

EMN Alerts

  • Big fall in Revenue (Y/Y)

EMN Stock Price

EMN RSI Chart

EMN Valuation

Market Cap

10.0B

Price/Earnings (Trailing)

12.61

Price/Sales (Trailing)

0.94

EV/EBITDA

7.47

Price/Free Cashflow

27.47

EMN Price/Sales (Trailing)

EMN Profitability

EBT Margin

8.60%

Return on Equity

13.34%

Return on Assets

4.62%

Free Cashflow Yield

3.64%

EMN Fundamentals

EMN Revenue

Revenue (TTM)

9.8B

Revenue Y/Y

-16.52%

Revenue Q/Q

-3.65%

EMN Earnings

Earnings (TTM)

708.0M

Earnings Y/Y

6.25%

Earnings Q/Q

102.99%

Price Action

52 Week Range

69.9192.21
(Low)(High)

Last 7 days

1.6%

Last 30 days

-5.9%

Trailing 12 Months

1.4%

EMN Financial Health

Current Ratio

1.34

EMN Investor Care

Dividend Yield

3.65%

Dividend/Share (TTM)

3.04

Diluted EPS (TTM)

5.94

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for EMN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-01
Holt Adrian James
acquired
119,022
61.51
1,935
svp, chf hr ofcr
2023-08-01
Holt Adrian James
sold
-165,713
85.64
-1,935
svp, chf hr ofcr
2023-05-04
RAISBECK DAVID W
acquired
-
-
1,396
-
2023-05-04
Holder Julie Fasone
acquired
-
-
1,396
-
2023-05-04
Haynesworth Linnie M
acquired
-
-
1,396
-
2023-05-04
Stevens Charles K. III
acquired
-
-
1,396
-
2023-05-04
OBRIEN JAMES J /KY
acquired
-
-
1,396
-
2023-05-04
BUTLER ERIC L
acquired
-
-
1,396
-
2023-04-13
WALKER KELLYE L.
acquired
-
-
18,701
evp, clo & corp. secretary
2023-04-13
WALKER KELLYE L.
sold (taxes)
-464,927
83.38
-5,576
evp, clo & corp. secretary

1–10 of 50

Which funds bought or sold EMN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-19
BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL
unchanged
-
-1,829
246,974
0.10%
2023-09-12
Farther Finance Advisors, LLC
added
24.27
14,934
78,864
0.02%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
reduced
-3.19
-2,476
60,948
0.02%
2023-08-28
DT Investment Partners, LLC
unchanged
-
91.00
2,401
-%
2023-08-24
ProVise Management Group, LLC
added
5.37
27,281
621,035
0.06%
2023-08-24
Alberta Investment Management Corp
unchanged
-
-1,736
234,416
-%
2023-08-23
Stonebridge Capital Advisors LLC
added
134
20,981
36,837
-%
2023-08-22
COMERICA BANK
new
-
-
-
-%
2023-08-22
Asset Dedication, LLC
reduced
-2.16
-11,000
320,000
0.03%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-0.57
-218,000
16,534,000
0.16%

1–10 of 48

Latest Funds Activity

Are funds buying EMN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own EMN
No. of Funds

Schedule 13G FIlings of Eastman Chemical

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
capital world investors
0.0%
0
SC 13G/A
Feb 09, 2023
vanguard group inc
12.50%
14,994,249
SC 13G/A
Jan 31, 2023
blackrock inc.
7.2%
8,615,723
SC 13G/A
Jan 20, 2023
jpmorgan chase & co
8.2%
9,862,144
SC 13G/A
Feb 11, 2022
capital world investors
6.3%
8,452,732
SC 13G/A
Feb 09, 2022
vanguard group inc
11.92%
16,026,862
SC 13G/A
Feb 01, 2022
blackrock inc.
6.6%
8,855,207
SC 13G/A
Jan 10, 2022
jpmorgan chase & co
7.4%
10,068,435
SC 13G/A
Feb 16, 2021
capital world investors
7.5%
10,167,734
SC 13G
Feb 10, 2021
vanguard group inc
10.91%
14,774,094
SC 13G/A

Recent SEC filings of Eastman Chemical

View All Filings
Date Filed Form Type Document
Aug 03, 2023
4
Insider Trading
Aug 01, 2023
144
Notice of Insider Sale Intent
Jul 28, 2023
10-Q
Quarterly Report
Jul 27, 2023
8-K
Current Report
Jun 26, 2023
4/A
Insider Trading
Jun 22, 2023
11-K
Employee Benefit Details

Peers (Alternatives to Eastman Chemical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
34.0B
12.5B
-1.07% 37.74%
7.2
2.71
-3.90% 152.35%
20.5B
9.7B
-7.25% -39.15%
5.22
2.12
123.06% 1386.73%
13.9B
-
8.46% 30.48%
10.98
1.25
22.25% -35.45%
-
17.9B
-5.63% 12.72%
-
-
1.96% 21.57%
MID-CAP
10.0B
9.8B
-5.95% 1.41%
12.61
0.94
-10.03% -41.97%
6.1B
7.8B
-14.24% 6.57%
7.54
0.78
-20.33% -46.41%
4.4B
6.9B
-8.02% -1.27%
22.73
0.64
-19.93% -84.77%
3.3B
3.3B
-0.38% -0.41%
5.78
1.01
-3.65% 128.94%
-
5.1B
-3.30% 12.06%
-
-
9.03% 9.70%
SMALL-CAP
841.7M
1.7B
-8.79% -9.18%
7.56
0.49
-11.49% -43.12%
310.8M
4.1B
-24.91% -62.60%
-0.35
0.08
-23.57% -425.83%
186.2M
1.8B
-5.94% -32.46%
10.31
0.1
21.33% 123.48%

Eastman Chemical News

InvestorsObserver
Eastman Chemical Co (EMN) Stock: How Does it Score on Fundamental Metrics?.
InvestorsObserver,
20 hours ago

Returns for EMN

Cumulative Returns on EMN

2.4%


10-Year Cumulative Returns

5.1%


7-Year Cumulative Returns

-2.4%


5-Year Cumulative Returns

-0.7%


3-Year Cumulative Returns

Risks for EMN

What is the probability of a big loss on EMN?

86.9%


Probability that Eastman Chemical stock will be more than 20% underwater in next one year

55.4%


Probability that Eastman Chemical stock will be more than 30% underwater in next one year.

27.3%


Probability that Eastman Chemical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does EMN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Eastman Chemical was unfortunately bought at previous high price.

Drawdowns

Financials for Eastman Chemical

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-4.5%9,81810,27810,58010,90110,91210,78110,4769,9689,3708,6418,4738,4928,6959,1349,2739,4449,6669,92410,15110,13710,055
Gross Profit-4.1%2,0302,1162,1372,3202,4412,4522,5002,4672,3061,9961,9751,9462,0192,2372,2342,2032,3572,4722,4792,4702,413
  S&GA Expenses0%721721726762790807795761725678654656654664691682694718721743748
  R&D Expenses-2.7%254261264267265261254244234223226229232237234233234237235229228
EBITDA-100.0%-1,1931,2721,7781,8221,3461,4229388269298948801,0031,3351,2951,3571,4991,5991,6791,7861,724
EBITDA Margin-100.0%-0.12*0.12*0.16*0.17*0.12*0.14*0.09*0.09*0.11*0.11*0.10*0.12*0.15*0.14*0.14*0.16*0.16*0.17*0.18*0.17*
Interest Expenses-4.8%-197-188-182-182-188-194-198-201-204-208-210-212-214-214-218-222-226-232-235-237-240
Earnings Before Taxes-12.7%7728849771,4781,5181,0301,0825784475535305146379549029641,1101,2241,3101,4251,369
EBT Margin-100.0%-0.09*0.09*0.14*0.14*0.10*0.10*0.06*0.05*0.06*0.06*0.06*0.07*0.10*0.10*0.10*0.11*0.12*0.13*0.14*0.14*
Net Income2.3%7086927931,1701,2208188575113214944784725778087597679139991,0801,5371,448
Net Income Margin-100.0%-0.07*0.07*0.11*0.11*0.08*0.08*0.05*0.03*0.06*0.06*0.06*0.07*0.09*0.08*0.08*0.09*0.10*0.11*0.15*0.14*
Free Cashflow-100.0%-2833643006358441,0641,1751,1051,1251,0721,3251,2711,2621,0791,1181,0701,0671,015857968
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-1.4%14,77114,98314,66714,98514,87515,80615,51916,25916,09816,19516,08316,00915,97316,46516,00816,13716,25616,36115,99516,36216,260
  Current Assets-7.6%3,6713,9733,7784,1054,0034,9294,6464,8754,7383,7973,5413,5343,5263,8513,3213,4403,5163,5513,3653,6473,498
    Cash Equivalents-31.6%410599493461456487459717609540564650704680204207186195226193193
  Inventory0.8%1,9601,9441,8941,9751,8261,6711,5041,6301,5011,5051,3791,3381,4191,6591,6621,6951,7301,7041,5831,6251,532
  Net PPE2.7%5,4025,2585,1604,9824,9594,9974,9965,1725,1815,4665,5495,4895,4785,4985,5715,5345,5505,5765,6005,5705,570
  Goodwill-0.2%3,6973,7033,6643,6443,6633,6653,6414,0444,0534,4464,4654,4434,4254,4174,4314,4644,4814,4774,4674,5094,514
Liabilities-3.1%9,4199,7219,4319,5189,4689,8299,73110,05210,0709,8769,9759,8539,87510,2739,97610,04010,31010,44210,11710,36710,486
  Current Liabilities-6.2%2,7872,9713,2513,2073,1483,1362,9713,1132,2952,0162,0381,7891,8782,3151,7892,0802,2262,3521,8512,1532,068
  Short Term Borrowings-16.8%8441,0141,1261,0869799847471,046325324349370702895171642731862243728662
    LT Debt, Non Current-0.9%4,5934,6364,0253,9794,0124,3794,4124,4425,2235,2005,2695,4955,4315,3995,6115,5675,6245,6025,9255,8986,033
Shareholder's Equity0.4%5,2815,2625,1535,3845,4075,9775,7886,2076,0286,3196,1086,1566,0986,1926,0326,0975,9465,9195,8785,9955,774
  Retained Earnings2.0%9,1909,0138,9739,0658,8578,6948,5578,2788,0208,2608,0808,1428,0718,1337,9658,0297,8487,6757,5737,6267,292
  Additional Paid-In Capital0.7%2,3422,3252,3152,3012,1792,2622,1872,2752,2552,2192,1742,1342,1172,1092,1052,0922,0792,0602,0482,0362,021
Accumulated Depreciation0.8%7,9597,8957,7827,6637,7847,7567,6847,9667,8988,0617,9827,8437,6977,5847,5107,3647,2987,2207,1317,0346,943
Minority Interest-4.1%71.0074.0083.0083.0084.0084.0084.0087.0084.0086.0085.0081.0077.0075.0074.0077.0077.0076.0075.0075.0077.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations17.3%1,1219569759481,2391,4201,6191,5951,4901,5001,4551,7201,6941,6801,5041,5731,5521,5731,5431,4491,582
Cashflow From Investing-435.4%-8622573921,0161,004-47.00-29.00-559-470-392-394-402-462-456-480-508-503-510-463-528-539
Cashflow From Financing71.9%-307-1,093-1,321-2,204-2,385-1,424-1,690-966-1,113-1,249-704-878-712-737-1,043-1,045-1,054-1,054-1,040-920-1,071
  Dividend Payments-1.1%373377381383383379375371367362358354349346343336331325318313307

EMN Income Statement

2023-06-30
UNAUDITED CONSOLIDATED STATEMENTS OF EARNINGS, COMPREHENSIVE INCOME AND RETAINED EARNINGS - USD ($)
$ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Sales$ 2,324$ 2,784$ 4,736$ 5,498
Cost of sales1,7402,1143,6234,278
Gross profit5846701,1131,220
Selling, general and administrative expenses185185376381
Research and development expenses6067122132
Asset impairments and restructuring charges, net0192221
Other components of post-employment (benefit) cost, net(3)(34)(6)(65)
Other (income) charges, net1914302
Gain on divested business0(7)0(10)
Earnings before interest and taxes323426569759
Net interest expense544510691
Earnings before income taxes269381463668
(Benefit from) provision for income taxes(3)12457175
Net earnings272257406493
Less: Net earnings attributable to noncontrolling interest0102
Net earnings attributable to Eastman$ 272$ 256$ 406$ 491
Earnings Per Share, Basic [Abstract]    
Basic earnings per share attributable to Eastman$ 2.28$ 2.05$ 3.41$ 3.87
Diluted earnings per share attributable to Eastman    
Diluted earnings per share attributable to Eastman$ 2.27$ 2.03$ 3.39$ 3.82
Comprehensive Income    
Net earnings including noncontrolling interest$ 272$ 257$ 406$ 493
Other comprehensive income (loss), net of tax:    
Change in cumulative translation adjustment(42)16(43)23
Defined benefit pension and other postretirement benefit plans:    
Amortization of unrecognized prior service credits(5)(9)(10)(15)
Derivatives and hedging:    
Unrealized gain (loss) during period(5)27(12)67
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax1(32)(1)(36)
Total other comprehensive income (loss), net of tax(51)2(66)39
Comprehensive income including noncontrolling interest221259340532
Less: Net earnings attributable to noncontrolling interest0102
Comprehensive income attributable to Eastman221258340530
Retained Earnings    
Retained earnings at beginning of period9,0138,6948,9738,557
Net earnings attributable to Eastman272256406491
Cash dividends declared(95)(93)(189)(191)
Retained earnings at end of period$ 9,190$ 8,857$ 9,190$ 8,857

EMN Balance Sheet

2023-06-30
UNAUDITED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 410$ 493
Trade receivables, net of allowance for credit losses923957
Miscellaneous receivables282320
Inventories1,9601,894
Other current assets96114
Total current assets3,6713,778
Properties  
Properties and equipment at cost13,36112,942
Less: Accumulated depreciation7,9597,782
Net properties5,4025,160
Goodwill3,6973,664
Intangible assets, net of accumulated amortization1,1801,210
Other noncurrent assets821855
Total assets14,77114,667
Current liabilities  
Payables and other current liabilities1,9432,125
Borrowings due within one year8441,126
Total current liabilities2,7873,251
Long-term borrowings4,5934,025
Deferred income tax liabilities573671
Post-employment obligations622628
Other long-term liabilities844856
Total liabilities$ 9,419$ 9,431
Common stock, shares issued (in shares)222,729,135222,348,557
Common stock, par value (in dollars per share)$ 0.01 
Stockholders' equity  
Common stock ($0.01 par value – 350,000,000 shares authorized; shares issued – 222,729,135 and 222,348,557 as of June 30, 2023 and December 31, 2022, respectively)$ 2$ 2
Additional paid-in capital2,3422,315
Retained earnings9,1908,973
Accumulated other comprehensive income (loss)(271)(205)
 Stockholder's Equity before Treasury Stock11,26311,085
Less: Treasury stock at cost (104,224,199 and 103,602,488 shares as of June 30, 2023 and December 31, 2022, respectively)5,9825,932
Total Eastman stockholders' equity5,2815,153
Noncontrolling interest7183
Total equity5,3525,236
Total liabilities and stockholders' equity$ 14,771$ 14,667
Treasury stock at cost (in shares)104,224,199103,602,488
Common stock, shares authorized (in shares)350,000,000 
Mark J. Costa
14000
Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insoluble sulfur and anti-degradant rubber additives; and performance resins. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral (PVB) sheets, and window and protective films, and aftermarket applied film products for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables markets. The company's Chemical Intermediates segment offers methylamines and salts higher amines and solvents; Olefin and acetyl derivatives, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non- phthalate plasticizers to the industrial chemicals and processing, building and construction, health and wellness, and agrochemicals. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.